News

Filter

Current filters:

Pricing

176 to 185 of 97217 results

Patient access to novel non-insulin treatments is sub-optimal in China

05-12-2014

With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is…

AstraZenecaByettaChinaDiabetesHealthcareJanuviaMarkets & MarketingMerck & CoPharmaceutical

Takeda receives Breakthrough designation for ixazomib

Takeda receives Breakthrough designation for ixazomib

05-12-2014

Japanese drug major Takeda Pharmaceutical’s has been granted Breakthrough Therapy designation from…

ixazomibPharmaceuticalRare diseasesRegulationTakeda PharmaUSA

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

05-12-2014

The US Food and Drug Administration has granted tentative approval for New Drug Applications by US generic…

Abacavir Sulfate and Lamivudine TabletsAnti-viralsGenericsMylanRegulationUSA

Credit Suisse sees PTC Therapeutics as a top stock pick

05-12-2014

Credit Suisse has released a biotech research report from analysts Jason Kantor and Jeremiah Shepard…

BiotechnologyFinancialNeurologicalPTC TherapeuticsRare diseasesRegulationTranslarna

AusBiotech argues for boosting commercial returns from research

05-12-2014

Trade group AusBiotech has made a submission to the Australian federal government’s consultation regarding…

AustraliaBiotechnologyFinancialPoliticsResearch

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

05-12-2014

The current pipeline of treatments for Parkinson’s disease is a site of great innovation, with 37%…

GBI ResearchGeriatricsNeurologicalPharmaceuticalResearch

US FDA approves new indication for Incyte’s Jakafi

US FDA approves new indication for Incyte’s Jakafi

05-12-2014

The US Food and Drug Administration yesterday approved a new use for Incyte Corp’s Jakafi (ruxolitinib)…

BiotechnologyIncyteJakafiOncologyRegulationUSA

GlaxoSmithKline abandons plans to divest Established Products portfolio

05-12-2014

In what has come as something of a surprise, UK pharma major GlaxoSmithKline has abandoned its plan to…

EuropeGlaxoSmithKlineMergers & AcquisitionsNorth AmericaPharmaceutical

176 to 185 of 97217 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top